Profil
Edgar D.
Charles is Chief Medical Officer at Climb Bio, Inc. since 2025.
Dr. Charles was Vice President at Bristol Myers Squibb Co. from 2015 to 2025.
Dr. Charles completed undergraduate studies at The University of Chicago, graduate studies at The Rockefeller University, and earned a doctorate from The University of Alabama School of Medicine.
Aktiva positioner av Edgar Charles
| Företag | Position | Start |
|---|---|---|
| CLIMB BIO, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-18 |
Tidigare kända positioner av Edgar Charles
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Företagsledare/Principal | 2025-01-01 |
Edgar Charless utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama School of Medicine
The University of Alabama School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
















